How Big is the Peripheral Neuropathy Market | Manufacturers & Commercial 2025

Code: MTA7903 Publication Date: Aug 2025

What is the size of Peripheral Neuropathy Market?

According to 6Wresearch internal database and industry insights, Global Peripheral Neuropathy Market was estimated at USD 5.2 billion in 2024 and is projected to reach USD 8.1 billion by 2031, expanding at a CAGR of 6.50% during the forecast period 2025–2031.

Peripheral Neuropathy Market is continued to grow due to several factors which include increasing prevalence of diabetic neuropathy, rising geriatric population, and growing awareness about early diagnosis and treatment options.

Key Growth Drivers of the Peripheral Neuropathy Market

  • Rising cases of diabetes and associated neuropathy complications
  • Increasing aging population prone to nerve disorders
  • Advancements in diagnostic tools and treatment therapies
  • Growing demand for effective pain management solutions
  • Rising healthcare expenditure and insurance coverage

Peripheral Neuropathy Market Trends

Peripheral Neuropathy Market is experiencing the steady growth with strong trends include the increasing adoption of advanced diagnostic techniques such as nerve conduction studies and skin biopsy. There is a surge noticed in the personalized medicine and targeted therapies is enhancing treatment effectiveness. The use of combination therapies including pharmacological and non-pharmacological approaches is growing gradually. Further, the telemedicine and remote patient monitoring are rising in demand as it improves disease management and patient outcomes.

Emerging Developments in the Peripheral Neuropathy Market

Peripheral Neuropathy Market is seeing number of developments with continuous research, which is ongoing for novel neuroprotective agents and regenerative therapies to restore nerve function. Some other examples are, development of wearable devices and digital health solutions aids in continuous symptom tracking. Further, the clinical trials for new drug formulations and improved delivery systems are notable. Also, the patient education and awareness campaigns enhance the early diagnosis and adherence to treatment.

List of Leading Companies in the Peripheral Neuropathy Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Pfizer Inc.

Company NamePfizer Inc.
Established Year1849
HeadquartersNew York, United States
Official WebsiteClick Here

This is a global biopharmaceutical company offering treatments for neuropathic pain and diabetic neuropathy complications.

2. Eli Lilly and Company

Company NameEli Lilly and Company
Established Year1876
HeadquartersIndianapolis, United States
Official WebsiteClick Here

This company develops medications for nerve pain and peripheral neuropathy that focus on innovative pharmaceutical solutions.

3. Astellas Pharma Inc.

Company NameAstellas Pharma Inc.
Established Year2005
HeadquartersTokyo, Japan
Official WebsiteClick Here

This company provides therapies targeting neuropathic conditions with a strong R&D focus on neurological disorders.

4. AbbVie Inc.

Company NameAbbVie Inc.
Established Year2013
HeadquartersIllinois, United States
Official WebsiteClick Here

This company offers pain management drugs and therapies addressing peripheral neuropathy symptoms and complications.

5. Novartis AG

Company NameNovartis AG
Established Year1996
HeadquartersBasel, Switzerland
Official WebsiteClick Here

This is one of the oldest companies who develops innovative treatments including nerve repair agents and symptom relief medications.

6. Horizon Therapeutics plc

Company NameHorizon Therapeutics plc
Established Year2008
HeadquartersDublin, Ireland
Official WebsiteClick Here

This company is one who specializes in rare diseases and neurological disorders including the peripheral neuropathy treatments.

7. Mitsubishi Tanabe Pharma Corporation

Company NameMitsubishi Tanabe Pharma Corporation
Established Year2007
HeadquartersOsaka, Japan
Official WebsiteClick Here

This company focuses on drug development for neurological conditions which include the neuropathic pain management.

8. Abbott Laboratories

Company NameAbbott Laboratories
Established Year1888
HeadquartersIllinois, United States
Official WebsiteClick Here

This company provides diagnostic tools and therapeutic products for managing peripheral neuropathy and related disorders.

How Big is the Peripheral Neuropathy Market : FAQs

The Peripheral Neuropathy market was estimated at USD 5.2 billion in 2024 and is projected to reach USD 8.1 billion by 2031.
Growth factors include rising diabetes cases, aging population, and advances in diagnosis and treatment.
Pharmaceutical, healthcare providers, and specialized pain management clinics lead adoption.
Major companies include Pfizer, Eli Lilly, Astellas, AbbVie, Novartis, Horizon Therapeutics, Mitsubishi Tanabe, and Abbott.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All